Joel Baglole

Joel Baglole

Joel Baglole has been a financial reporter for more than 20 years. For five years, Mr. Baglole was a staff reporter at The Wall Street Journal, where he wrote articles from Iceland to Indonesia and covered topics ranging from the automotive and airline industries to investment banks and global stock markets.

Mr. Baglole has also worked for The Washington Post and Toronto Star newspapers, and has contributed to business focused websites such as The Motley Fool and Investopedia. At InvestorPlace, he covers a wide range of large and small cap stocks, as well as political and economic issues that impact financial markets.

Check out Joel’s TipRanks profile.

Recent Articles

Cathie Wood Keeps Buying Ginkgo Bioworks (DNA) Stock

The famed investor who focuses on disruptive technologies has been buying DNA stock hand-over-fist in recent days.

Carl Icahn Just Made a Big Bet on Twitter (TWTR) Stock

Famed investor Carl Icahn has a big stake in Twitter, holding more than $500 million of the social media company's stock.

7 Growth Stocks That Are Too Cheap to Ignore

These leading growth names are available to investors at discounted prices thanks to this year's market selloff.

7 Most Undervalued Stocks to Buy Now

The market downturn has lowered the prices of some of the best stocks available to investors, creating great, undervalued stocks to buy now.

Why Is Myovant Sciences (MYOV) Stock Up 30% Today?

The prospect that shareholders could get 27% or more to tender their shares has MYOV stock up sharply today.